In the study of congenital hyperinsulinism now enrolling phase III sunRIZE trial

sunrize logo

XOMA 358, a Novel Treatment for Hyperinsulinemic Hypoglycemia: Safety and Clinical Pharmacology from the First in Human Trial

Back to Careers

ENDO 2015 Annual Meeting